JP2002527513A5 - - Google Patents

Download PDF

Info

Publication number
JP2002527513A5
JP2002527513A5 JP2000577165A JP2000577165A JP2002527513A5 JP 2002527513 A5 JP2002527513 A5 JP 2002527513A5 JP 2000577165 A JP2000577165 A JP 2000577165A JP 2000577165 A JP2000577165 A JP 2000577165A JP 2002527513 A5 JP2002527513 A5 JP 2002527513A5
Authority
JP
Japan
Prior art keywords
compound
compound according
ring
substituted
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000577165A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002527513A (ja
Filing date
Publication date
Priority claimed from US09/173,642 external-priority patent/US6133291A/en
Application filed filed Critical
Publication of JP2002527513A publication Critical patent/JP2002527513A/ja
Publication of JP2002527513A5 publication Critical patent/JP2002527513A5/ja
Pending legal-status Critical Current

Links

JP2000577165A 1998-10-16 1999-10-15 ヒスタミン−h3アゴニストまたはアンタゴニストとしてのn−(イミダゾリルアルキル)置換環式アミン Pending JP2002527513A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/173,642 1998-10-16
US09/173,642 US6133291A (en) 1998-10-16 1998-10-16 N-(imidazolylalkyl)substituted cyclic amines as histamine-H3 agonists or antagonists
PCT/US1999/021461 WO2000023438A1 (en) 1998-10-16 1999-10-15 N-(imidazolylalkyl)substituted cyclic amines as histamine-h3 agonists or antagonists

Publications (2)

Publication Number Publication Date
JP2002527513A JP2002527513A (ja) 2002-08-27
JP2002527513A5 true JP2002527513A5 (cg-RX-API-DMAC7.html) 2006-09-28

Family

ID=22632924

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000577165A Pending JP2002527513A (ja) 1998-10-16 1999-10-15 ヒスタミン−h3アゴニストまたはアンタゴニストとしてのn−(イミダゾリルアルキル)置換環式アミン

Country Status (10)

Country Link
US (1) US6133291A (cg-RX-API-DMAC7.html)
EP (1) EP1121354B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002527513A (cg-RX-API-DMAC7.html)
CN (1) CN1198817C (cg-RX-API-DMAC7.html)
AT (1) ATE284398T1 (cg-RX-API-DMAC7.html)
AU (1) AU1092800A (cg-RX-API-DMAC7.html)
CA (1) CA2346436A1 (cg-RX-API-DMAC7.html)
DE (1) DE69922528T2 (cg-RX-API-DMAC7.html)
ES (1) ES2229782T3 (cg-RX-API-DMAC7.html)
WO (1) WO2000023438A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7361666B2 (en) 1999-05-25 2008-04-22 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US6635661B2 (en) 2000-05-25 2003-10-21 Sepracor Inc. Heterocyclic analgesic compounds and methods of use thereof
US6677332B1 (en) 1999-05-25 2004-01-13 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
AU2001238690A1 (en) 2000-03-14 2001-09-24 Sepracor, Inc. 3-substituted piperidines comprising urea functionality, and methods of use thereof
WO2001092226A1 (en) * 2000-05-25 2001-12-06 Sepracor, Inc. Heterocyclic analgesic compounds and method of use thereof
WO2002044141A2 (en) * 2000-09-20 2002-06-06 Schering Corporation Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
FR2827863A1 (fr) * 2001-07-27 2003-01-31 Sanofi Synthelabo Derives d'aminoalkylimidazole, leur preparation et leur utilisation en therapeutique
KR100432577B1 (ko) 2002-02-08 2004-05-24 주식회사유한양행 이미다졸 유도체의 제조방법
RU2323935C2 (ru) * 2002-04-18 2008-05-10 Шеринг Корпорейшн Производные бензимидазола, их применение и фармацевтическая композиция на их основе, обладающая свойствами антагониста рецептора гистамина h3
MY135686A (en) * 2002-06-24 2008-06-30 Schering Corp Indole derivatives useful as histamine h3 antagonists
US7880017B2 (en) 2003-11-11 2011-02-01 Allergan, Inc. Process for the synthesis of imidazoles
US7183305B2 (en) 2003-11-11 2007-02-27 Allergan, Inc. Process for the synthesis of imidazoles
CA2609957A1 (en) * 2005-06-20 2007-01-04 Schering Corporation Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists
US20100210633A1 (en) * 2006-10-12 2010-08-19 Epix Delaware, Inc. Carboxamide compounds and their use
AU2008335135A1 (en) 2007-12-11 2009-06-18 Cytopathfinder, Inc. Carboxamide compounds and their use as chemokine receptor agonists
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
EP3233077B1 (en) 2014-12-19 2026-05-06 The Broad Institute, Inc. Dopamine d2 receptor ligands
EP3233799B1 (en) * 2014-12-19 2021-05-19 The Broad Institute, Inc. Dopamine d2 receptor ligands

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4006137A (en) * 1975-08-21 1977-02-01 E. R. Squibb & Sons, Inc. 2-Ethenyl imidazolium derivatives
ZA792608B (en) * 1978-05-30 1980-06-25 Smith Kline French Lab Nitro compounds
JPS6287573A (ja) * 1985-10-11 1987-04-22 Banyu Pharmaceut Co Ltd 四級アンモニウム塩の製造法
GB8916947D0 (en) * 1989-07-25 1989-09-13 Smith Kline French Lab Medicaments
GB9115740D0 (en) * 1991-07-20 1991-09-04 Smithkline Beecham Plc Medicaments
NZ246434A (en) * 1991-12-18 1996-02-27 Schering Corp Imidazoylalkyl substituted by a six membered nitrogen containing heterocycle; pharmaceutical compositions and preparatory methods
DE69212844T2 (de) * 1991-12-18 1997-01-09 Schering Corp., Kenilworth, N.J. Imidazolyl oder imidazolylalkyl substituiert mit einem 4- oder 5-gliedrigen stickstoff enthaltenden heterozyklischen ring
AU662588B2 (en) * 1991-12-18 1995-09-07 Schering Corporation Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine H3 agonists/antagonists
US5807872A (en) * 1992-12-16 1998-09-15 Schering Corporation Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring
FI92843C (fi) * 1993-02-25 1995-01-10 Eija Anitta Maeensivu Uusi menetelmä optisesti aktiivisten glyserolijohdannaisten valmistamiseksi
NZ276883A (en) * 1993-11-15 1998-08-26 Schering Corp 1h-imidazol-4-yl)alkyl]benzene derivatives
FR2732017B1 (fr) * 1995-03-21 2000-09-22 Inst Nat Sante Rech Med Nouveaux derives de l'imidazole antagonistes et/ou agonistes du recepteur h3 de l'histamine, leur preparation et leurs applications therapeutiques
CA2222652A1 (en) * 1995-06-07 1996-12-19 Gliatech, Inc. 1h-4(5)-substituted imidazole derivatives

Similar Documents

Publication Publication Date Title
JP2023542555A (ja) Jak阻害剤の結晶多形フォームa及びその調製方法
JP2005519932A5 (cg-RX-API-DMAC7.html)
JP2004501930A5 (cg-RX-API-DMAC7.html)
JP2022512588A5 (cg-RX-API-DMAC7.html)
JP2002539128A5 (cg-RX-API-DMAC7.html)
RU2003117476A (ru) Аминотиазолы и их применение в качестве антагонистов рецептора аденозина
JP2008505157A5 (cg-RX-API-DMAC7.html)
JP2003519676A5 (cg-RX-API-DMAC7.html)
KR900012919A (ko) 벤조 융합된 n-함유 헤테로사이클 유도체
JP2006504766A5 (cg-RX-API-DMAC7.html)
RU2000116011A (ru) Пероральная фармацевтическая лекарственная форма с продолжительным высвобождением
JP2001525411A5 (cg-RX-API-DMAC7.html)
JP2006509749A5 (cg-RX-API-DMAC7.html)
RU2006137706A (ru) 9-замещенное производное 8-оксоаденина
JP2001526218A5 (cg-RX-API-DMAC7.html)
JP2002030084A5 (cg-RX-API-DMAC7.html)
RU2009114859A (ru) Производные бензимидазола в качестве селективных ингибиторов кислотной помпы
JP2023538524A5 (cg-RX-API-DMAC7.html)
JP2007505931A5 (cg-RX-API-DMAC7.html)
JP2006524706A5 (cg-RX-API-DMAC7.html)
JP2002505286A5 (cg-RX-API-DMAC7.html)
JP2003512327A5 (cg-RX-API-DMAC7.html)
JP2010095550A (ja) キノリン誘導体
JP2002517390A (ja) Hivインテグラーゼ阻害薬
JP2002505328A (ja) 抗潰瘍医薬の硝酸塩